Back to Newsroom

Auris Medical to Host Scientific Symposium at IFOS ENT World Congress in Paris

Zug, Switzerland, June 22, 2017 — Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced that the company will host a scientific symposium on acute hearing loss at the 21st IFOS ENT World Congress in Paris. The symposium titled “Recent Advances in the Treatment of Acute Hearing Loss” will feature several experts in the field of hearing loss research. The event will take place on Monday, June 26, 2017, at 12:30 pm CEST. Following the symposium, the presentation will be available in the Events & Presentations section of the Auris Medical website at www.aurismedical.com.
READ MORE…